CUSIP: 03842B101
Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,678,323
-
Share change
-
+4,665,834
-
Total reported value
-
$59,557,000
-
Price per share
-
$12.73
-
Number of holders
-
23
-
Value change
-
+$59,398,000
-
Number of buys
-
22
Quarterly Holders Quick Answers
What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03842B101:
Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q1 2014
As of 31 Mar 2014,
AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,678,323 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, DRIEHAUS CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, Visium Asset Management, LP, HIGHLAND CAPITAL MANAGEMENT LP, Cormorant Asset Management, LLC, SPHERA FUNDS MANAGEMENT LTD., PERCEPTIVE ADVISORS LLC, and BlackRock Advisors LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.